BridgeMD
Compares treatment options for Hallux Valgus Deformity
Official title Operative Versus Non-operative Treatment for Mild to Moderate Hallux Valgus Deformity
ClinicalTrials.gov ID: NCT06114043
What this study is testing
- What it's testing
- The goal of this randomized controlled trial is to investigate operative treatment versus conservative treatment in participants suffering from mild to moderate hallux valgus deformity. The main question it aims to answer are; Is surgery superior to conservative treatment?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Painful Hallux Valgus deformity
- Hallux Valgus Angle \<35 degrees
- Intermetatarsal angle \<15 degrees
- 18-80 years
You likely can't join if
- Advanced osteoarthritis in first metatarsophalangeal joint
- Rheumatic diseases
- Pregnancy
- Drug abuse
- Severe psychological disorder
- Lack of compliance
See the full eligibility criteria
- Painful Hallux Valgus deformity
- Hallux Valgus Angle \<35 degrees
- Intermetatarsal angle \<15 degrees
- 18-80 years
- Advanced osteoarthritis in first metatarsophalangeal joint
- Rheumatic diseases
- Pregnancy
- Drug abuse
- Severe psychological disorder
- Lack of compliance
- Language barrier
The study team makes the final eligibility decision.
Where it's taking place
- Sarpsborg, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sarpsborg, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.